Gurkirpal Singh

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study
    Gurkirpal Singh
    Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, Calif 94301, USA
    Am J Med 119:255-66. 2006
  2. ncbi request reprint Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam
    Gurkirpal Singh
    Divisions of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
    Am J Med 117:100-6. 2004
  3. pmc Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis
    Gurkirpal Singh
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 100 Hamilton Avenue, Suite 225 42, Palo Alto, CA 94301, USA
    Arthritis Res Ther 8:R153. 2006
  4. ncbi request reprint Arthritis, Rheumatism and Aging Medical Information System Post-Marketing Surveillance Program
    G Singh
    Department of Medicine, Stanford University School of Medicine, Palo Alto, California 94304, USA
    J Rheumatol 28:1174-9. 2001
  5. ncbi request reprint Understanding NSAID-PPI-COX-2 interrelationships
    Gurkirpal Singh
    Stanford University, Palo Alto, California, USA
    Drugs Today (Barc) 40:21-4. 2004
  6. pmc Concurrent conditions in patients with chronic constipation: a population-based study
    Gaurav Arora
    Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
    PLoS ONE 7:e42910. 2012
  7. ncbi request reprint Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage
    G Singh
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA 94062, USA
    Int J Clin Pract 59:1210-7. 2005
  8. doi request reprint Effects of long-term corticosteroid usage on functional disability in patients with early rheumatoid arthritis, regardless of controlled disease activity
    Eiichi Tanaka
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA
    Rheumatol Int 32:749-57. 2012
  9. doi request reprint Proximal and distal colorectal cancer resection rates in the United States since widespread screening by colonoscopy
    Parvathi A Myer
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California 94063, USA
    Gastroenterology 143:1227-36. 2012
  10. doi request reprint Medical care costs of patients with rheumatoid arthritis during the prebiologics period in Japan: a large prospective observational cohort study
    Eiichi Tanaka
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA
    Mod Rheumatol 20:46-53. 2010

Collaborators

Detail Information

Publications31

  1. ncbi request reprint Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study
    Gurkirpal Singh
    Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, Calif 94301, USA
    Am J Med 119:255-66. 2006
    ..To evaluate the efficacy and upper gastrointestinal (UGI) safety of celecoxib, compared with nonspecific nonsteroidal anti-inflammatory drugs (NSAIDs), among patients with osteoarthritis...
  2. ncbi request reprint Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam
    Gurkirpal Singh
    Divisions of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
    Am J Med 117:100-6. 2004
    ..To assess the risk of serious gastrointestinal and thromboembolic complications with approved doses of meloxicam...
  3. pmc Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis
    Gurkirpal Singh
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 100 Hamilton Avenue, Suite 225 42, Palo Alto, CA 94301, USA
    Arthritis Res Ther 8:R153. 2006
    ..Nonselective NSAIDs are frequently prescribed, and so further investigation into the risk of AMI is warranted because the potential for harm can be substantial...
  4. ncbi request reprint Arthritis, Rheumatism and Aging Medical Information System Post-Marketing Surveillance Program
    G Singh
    Department of Medicine, Stanford University School of Medicine, Palo Alto, California 94304, USA
    J Rheumatol 28:1174-9. 2001
    ..The ARAMIS-PMS program aims to study patients in normal clinical setting to evaluate the real-life effectiveness, toxicity, and cost effectiveness of various medications used to treat rheumatic diseases...
  5. ncbi request reprint Understanding NSAID-PPI-COX-2 interrelationships
    Gurkirpal Singh
    Stanford University, Palo Alto, California, USA
    Drugs Today (Barc) 40:21-4. 2004
    ..Finally, the combination of a COX-2 inhibitor with a PPI has shown promise in patients with previous NSAID-related gastrointestinal complications who are at high risk for reinjury...
  6. pmc Concurrent conditions in patients with chronic constipation: a population-based study
    Gaurav Arora
    Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
    PLoS ONE 7:e42910. 2012
    ..Chronic constipation (CC) is a common condition but its concurrent conditions are not well characterized. We measured the prevalence and risk of developing 15 pre-specified concurrent conditions in patients with CC...
  7. ncbi request reprint Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage
    G Singh
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA 94062, USA
    Int J Clin Pract 59:1210-7. 2005
    ..PPIs have an excellent safety profile, and pantoprazole--with its low potential for drug-drug interactions--is particularly suitable for administration to elderly patients who often require concomitant treatment with other medications...
  8. doi request reprint Effects of long-term corticosteroid usage on functional disability in patients with early rheumatoid arthritis, regardless of controlled disease activity
    Eiichi Tanaka
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA
    Rheumatol Int 32:749-57. 2012
    ..05). Frequent steroid usage was associated with significantly higher final J-HAQ scores in early RA patients, even though their disease was managed efficiently by maintaining the DAS28 values under 3.2 over a long-term period...
  9. doi request reprint Proximal and distal colorectal cancer resection rates in the United States since widespread screening by colonoscopy
    Parvathi A Myer
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California 94063, USA
    Gastroenterology 143:1227-36. 2012
    ..We examined US trends in rates of resection for proximal vs distal CRC, which reflect CRC incidence, in the context of national CRC screening data, before and since Medicare's 2001 decision to pay for screening colonoscopy...
  10. doi request reprint Medical care costs of patients with rheumatoid arthritis during the prebiologics period in Japan: a large prospective observational cohort study
    Eiichi Tanaka
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA
    Mod Rheumatol 20:46-53. 2010
    ..001). Outpatient costs for patients with RA increased year after year over the 4-year period under observation in Japan. Medical costs were higher with increasing RA disease activity and disability levels...
  11. ncbi request reprint Treatment options for osteoarthritis
    Gurkirpal Singh
    Department of Medicine, Division of Immunology and Rheumatology Stanford University School of Medicine, Palo Alto, California, USA
    Surg Technol Int 11:287-92. 2003
    ..The former, however, have not been shown unequivocally to be effective. Future treatment modalities for OA are geared toward reversing the disease process and may include disease-modifying drugs and gene therapy...
  12. ncbi request reprint Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis
    Eswar Krishnan
    Stanford University, Division of Immunology, Department of Medicine, 1000 Welch Rd, Suite 203, Palo Alto, Calif, USA
    Circulation 110:1774-9. 2004
    ..The impact of this on atherosclerotic cardiovascular diseases is not known...
  13. pmc GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded endpoint (PROBE) trial
    Byron Cryer
    University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    Am J Gastroenterol 108:392-400. 2013
    ..The objective of this study was to assess if celecoxib is associated with a lower incidence of clinically significant upper and/or lower GI events than nonselective NSAIDs (nsNSAIDs) in standard clinical practice...
  14. doi request reprint Clinical and economic burden of emergency department visits due to gastrointestinal diseases in the United States
    Parvathi A Myer
    Division of Gastroenterology, Department of Medicine, Stanford University, Stanford, CA, USA
    Am J Gastroenterol 108:1496-507. 2013
    ..Gastrointestinal (GI) emergencies may cause substantial morbidity. Our aims were to characterize the national clinical and economic burden of GI visits to emergency departments (EDs) in the United States...
  15. ncbi request reprint Proton pump inhibitors for gastroduodenal damage related to nonsteroidal anti-inflammatory drugs or aspirin: twelve important questions for clinical practice
    Gaurav Arora
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California 94305 5187, USA
    Clin Gastroenterol Hepatol 7:725-35. 2009
    ..We then summarized our recommendations on the use of PPIs for the clinical management of patients using NSAIDs or aspirin...
  16. ncbi request reprint Use of health care resources and cost of care for adults with constipation
    Gurkirpal Singh
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California, USA
    Clin Gastroenterol Hepatol 5:1053-8. 2007
    ..To evaluate the clinical and fiscal effects of constipation, we assessed health care resource use by patients with constipation enrolled in a large state Medicaid program...
  17. ncbi request reprint Risk of perforation from a colonoscopy in adults: a large population-based study
    Gaurav Arora
    Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California 94305 5187, USA
    Gastrointest Endosc 69:654-64. 2009
    ..Previous studies that reported the incidence of perforation from a colonoscopy are limited by small sample sizes, restricted age groups, or single-center data...
  18. ncbi request reprint Utilization and antiviral therapy in patients with chronic hepatitis C: analysis of ambulatory care visits in the US
    Ramsey Cheung
    Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA, USA
    Dig Dis Sci 55:1744-51. 2010
    ..Studies on mostly veterans found the majority of chronic hepatitis C (CHC) patients were not treated. Little information exists on a broad-based population...
  19. pmc Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization
    Uri Ladabaum
    Division of Gastroenterology, Stanford University, Stanford, California, USA
    Clin Gastroenterol Hepatol 10:37-45. 2012
    ..We aimed to characterize practice patterns for patients with IBS in a large health maintenance organization, analyzing point of diagnosis, testing, comorbidities, and treatment...
  20. ncbi request reprint Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey
    Gurkirpal Singh
    ARAIS PMS Program, Stanford University School of Medicine, Palo Alto, California, USA
    Am J Manag Care 8:S383-91. 2002
    ..To estimate the prevalence of traditional risk factors for cardiovascular disease (CVD) among US adults with osteoarthritis (OA)...
  21. doi request reprint Epidemiology of alcohol-related liver and pancreatic disease in the United States
    Alice L Yang
    Department of Medicine, Division of Gastroenterology and Hepatology, Veterans Affairs Palo Alto Health Care System and Stanford University, 3801 Miranda Ave 154J, Palo Alto, CA, USA
    Arch Intern Med 168:649-56. 2008
    ..To better understand alcohol-related liver and pancreas effects on and associations with different ethnic groups and sexes, we analyzed the trends of AP, CP, AH, CH, AP plus AH, and CP plus CH in the United States...
  22. ncbi request reprint Attrition bias in rheumatoid arthritis databanks: a case study of 6346 patients in 11 databanks and 65,649 administrations of the Health Assessment Questionnaire
    Eswar Krishnan
    Division of Rheumatology, Department of Medicine, Stanford University, Palo Alto, California, USA
    J Rheumatol 31:1320-6. 2004
    ..Patient dropout (attrition) can bias and threaten validity of databank-based studies. Although there are several databanks of rheumatoid arthritis (RA) in operation, this phenomenon has not been well studied...
  23. ncbi request reprint Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis
    John B Wong
    Division of Clinical Decision Making, Department of Medicine, Tupper Research Institute, Tufts New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA
    Am J Med 113:400-8. 2002
    ..To estimate the cost-effectiveness of infliximab plus methotrexate for active, refractory rheumatoid arthritis...
  24. ncbi request reprint Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheumatoid arthritis
    Yuko Matsuda
    Institute of Rheumatology, Tokyo Women s Medical University, 10 22 Kawada cho, Shinjuku ku, Tokyo 162 0054, Japan
    Arthritis Rheum 49:784-8. 2003
    ..To develop and validate a self-administered instrument for measuring functional status in Japanese-speaking rheumatoid arthritis patients...
  25. ncbi request reprint Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic review
    Delia Schaffer
    Pfizer Australia, Sydney, NSW, Australia
    Med J Aust 185:501-6. 2006
    ..Exposure to non-steroidal anti-inflammatory drugs (NSAIDs) is associated with increased risk of serious gastrointestinal (GI) events compared with non-exposure. We investigated whether that risk is sustained over time...
  26. ncbi request reprint The problem with NSAIDs: what data to believe?
    Gayle McKellar
    Center for Rheumatic Diseases, Glasgow Royal Infirmary, Castle Street, Glasgow G4 0SF, UK
    Curr Pain Headache Rep 11:423-7. 2007
    ..The US Food and Drug Administration has recommended that both classes of drugs carry a black box warning with regard to gastrointestinal and cardiovascular risks...
  27. ncbi request reprint Powering our way to the elusive side effect: a composite outcome 'basket' of predefined designated endpoints in each organ system should be included in all controlled trials
    Peter Tugwell
    Institute of Population Health, University of Ottawa, 1 Stewart Street, Room 312, Ottawa, Ontario K1N 6N5, Canada
    J Clin Epidemiol 58:785-90. 2005
    ..To review the methodological insights gained from the CLASS and VIGOR coxib trials and make suggestions for primary safety outcomes in future trials...
  28. doi request reprint Update on the use of analgesics versus nonsteroidal anti-inflammatory drugs in rheumatic disorders: risks and benefits
    Gayle McKellar
    Centre for Rheumatic Diseases, Glasgow Royal Infirmary, Glasgow, UK
    Curr Opin Rheumatol 20:239-45. 2008
    ..An evaluation of the potential risks and benefits of other analgesics has also followed. In this time of greater analysis of analgesic use, this review seeks to present the most recent evidence...
  29. ncbi request reprint Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis
    Gurkirpal Singh
    Medical Research International, Waltham, Massachusetts 02451 7341, USA
    J Rheumatol 30:714-9. 2003
    ..To estimate the potential effect on cardiovascular event occurrence and treatment costs associated with increases in systolic blood pressure (SBP) among patients with osteoarthritis (OA) and rheumatoid arthritis (RA)...
  30. ncbi request reprint Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan
    Hisashi Yamanaka
    Institute of Rheumatology, Tokyo Women s Medical University, 10 22 Kawada cho, Shinjuku ku, Tokyo, 162 0054, Japan
    Mod Rheumatol 17:283-9. 2007
    ..The suppression of disease activity resulted in a better outcome for patients...
  31. ncbi request reprint Nonsteroidal anti-inflammatory drug use does not affect short-term endoscopic and histologic outcomes after Helicobacter pylori eradication in patients with rheumatoid arthritis
    Eiichi Tanaka
    Institute of Rheumatology, Tokyo Women s Medical University, Tokyo 162 0054, Japan
    Mod Rheumatol 17:228-34. 2007
    ..5 months, use of NSAIDs in Japanese patients with RA did not impair the healing process of gastric and duodenal ulcers nor did it affect the endoscopic and histological improvements associated with H. pylori eradication...